RxDoctor Payments Data

Abby Teeters, PA

Physician Assistant · Nashville, TNNPI 1538875901

Payments from drug & device makers

$7,212in general payments, 2019–2025

Across 346 payments — averaging $20.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$2K
  • Novartis$887
  • AbbVie$733
  • AstraZeneca$553
  • UCB, Inc.$530
  • Johnson & Johnson$493
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$6,91796%
  • Education$2964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,212 in reported general payments places this provider in the 90th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$5,133
Medicare patients
52
Services billed
56

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept95$779,318
Humira(Cf) PenAdalimumab70$540,937
Taltz AutoinjectorIxekizumab49$357,254
Orencia ClickjectAbatacept40$231,947
OtezlaApremilast29$142,545
Xeljanz XrTofacitinib Citrate20$124,486
Cosentyx Sensoready PenSecukinumab14$102,095
Hydroxychloroquine Sulfate854$36,527
ProliaDenosumab15$26,262
Leflunomide168$19,090
MethotrexateMethotrexate Sodium584$15,938
Mycophenolate Mofetil26$4,261
Prednisone451$2,818
Celecoxib105$2,160
Etodolac79$2,121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenOtezla, Prolia$1,676$168,80644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →